230 related articles for article (PubMed ID: 51680)
21. Identification and solubilization of iodinated cell surface human melanoma associated antigens.
Bystryn JC; Smalley JR
Int J Cancer; 1977 Aug; 20(2):165-72. PubMed ID: 70412
[TBL] [Abstract][Full Text] [Related]
22. Separation of skin reactive intestinal cancer antigen from the carcinoembryonic antigen of Gold.
Hollinshead AC; McWright CG; Alford TC GLEW DH; Gold P; Herbeman RB
Science; 1972 Sep; 177(4052):887-9. PubMed ID: 5054642
[TBL] [Abstract][Full Text] [Related]
23. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
Kokoschka EM
Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
[No Abstract] [Full Text] [Related]
24. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
25. "Hidden" cytotoxic antibodies that react with allogeneic cultured fetal and tumor cells contained in soluble immune complexes from normal human sera.
Morgan AC; Rossen RD; McCormick KJ; Stehlin JS; Giovanella BC
Cancer Res; 1982 Mar; 42(3):881-7. PubMed ID: 7059986
[TBL] [Abstract][Full Text] [Related]
26. Soluble membrane antigens of human malignant melanoma cells.
Hollinshead AC; Herberman RB; Jaffurs WJ; Alpert LK; Minton JP; Harris JE
Cancer; 1974 Oct; 34(4):1235-43. PubMed ID: 4418174
[No Abstract] [Full Text] [Related]
27. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
[TBL] [Abstract][Full Text] [Related]
28. Immunodiagnosis of human melanoma: characterization of human melanoma antigens and their detection in sera of melanoma patients by radioimmunoassay.
Ishii Y; Mavligit GM
Oncology; 1982; 39(1):23-8. PubMed ID: 6173826
[TBL] [Abstract][Full Text] [Related]
29. Carcinoembryonic antigen. Its role in the evaluation of intraocular malignant tumors.
Michelson JB; Felberg NT; Shields JA
Arch Ophthalmol; 1976 Mar; 94(3):414-6. PubMed ID: 1267924
[TBL] [Abstract][Full Text] [Related]
30. Purification and characterisation of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4.
Pancino G; Osinaga E; Charpin C; Mistro D; Barque JP; Roseto A
Br J Cancer; 1991 Mar; 63(3):390-8. PubMed ID: 1706194
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous delayed hypersensitivity reactions to soluble melanoma antigen in patients with ocular malignant melanoma.
Char DH; Hollinshead A; Cogan DG; Ballintine EJ; Hogan MJ; Herberman RB
N Engl J Med; 1974 Aug; 291(6):274-7. PubMed ID: 4407111
[No Abstract] [Full Text] [Related]
32. Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells.
Hollinshead AC; Stewart TH; Herberman RB
J Natl Cancer Inst; 1974 Feb; 52(2):327-38. PubMed ID: 4131424
[No Abstract] [Full Text] [Related]
33. Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate.
Salcedo M; Bercovici N; Taylor R; Vereecken P; Massicard S; Duriau D; Vernel-Pauillac F; Boyer A; Baron-Bodo V; Mallard E; Bartholeyns J; Goxe B; Latour N; Leroy S; Prigent D; Martiat P; Sales F; Laporte M; Bruyns C; Romet-Lemonne JL; Abastado JP; Lehmann F; Velu T
Cancer Immunol Immunother; 2006 Jul; 55(7):819-29. PubMed ID: 16187085
[TBL] [Abstract][Full Text] [Related]
34. Isolation and characterization of a heterodimeric surface antigen on human melanoma cells and evidence that it is the 4F2 cell activation/proliferation molecule.
Dixon WT; Sikora LK; Demetrick DJ; Jerry LM
Int J Cancer; 1990 Jan; 45(1):59-68. PubMed ID: 2404879
[TBL] [Abstract][Full Text] [Related]
35. Sensitization of leukocytes of cancer patients against fetal antigens: leukocyte migration studies.
Zöller M; Matzku S; Schulz U; Price MR
J Natl Cancer Inst; 1979 Aug; 63(2):285-93. PubMed ID: 88534
[TBL] [Abstract][Full Text] [Related]
36. An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours.
Gatter KC; Ralfkiaer E; Skinner J; Brown D; Heryet A; Pulford KA; Hou-Jensen K; Mason DY
J Clin Pathol; 1985 Dec; 38(12):1353-7. PubMed ID: 3908491
[TBL] [Abstract][Full Text] [Related]
37. The expression of tumor-associated antigens in primary and metastatic human malignant melanoma.
Brüggen J; Bröcker EB; Suter L; Redmann K; Sorg C
Behring Inst Mitt; 1984 May; (74):19-23. PubMed ID: 6477352
[TBL] [Abstract][Full Text] [Related]
38. Detection of antigen-antibody complexes in cancer patients.
Rossen RD
Antibiot Chemother (1971); 1978; 22():5-15. PubMed ID: 341797
[No Abstract] [Full Text] [Related]
39. Melanoma antigens that produce cell-mediated immune responses in melanoma patients: joint U.S.-U.S.S.R. study.
Gorodilova VV; Hollinshead A
Science; 1975 Oct; 190(4212):391-2. PubMed ID: 1179218
[No Abstract] [Full Text] [Related]
40. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
Carrel S; Schreyer M; Gross N; Zografos L
Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
